AU7841998A - CHO cell sialidase by recombinant DNA technology - Google Patents

CHO cell sialidase by recombinant DNA technology

Info

Publication number
AU7841998A
AU7841998A AU78419/98A AU7841998A AU7841998A AU 7841998 A AU7841998 A AU 7841998A AU 78419/98 A AU78419/98 A AU 78419/98A AU 7841998 A AU7841998 A AU 7841998A AU 7841998 A AU7841998 A AU 7841998A
Authority
AU
Australia
Prior art keywords
sialidase
dna
recombinant dna
dna technology
cho cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78419/98A
Inventor
Mary B Sliwkowski
Thomas G Warner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU7841998A publication Critical patent/AU7841998A/en
Priority to AU16688/01A priority Critical patent/AU771747B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)

Abstract

A recombinant cell line has a constitutive sialidase whose functional expression is disrupted, for example by homologous recombination or using antisense RNA. Sialidase is purified from cell culture fluid of Chinese hamster ovary cells. DNA encoding sialidase is obtained using an oligonucleotide probe designed using amino acid sequence data on the sialidase, and the DNA is expressed in host cells transformed with the DNA.
AU78419/98A 1993-05-17 1998-07-27 CHO cell sialidase by recombinant DNA technology Abandoned AU7841998A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU16688/01A AU771747B2 (en) 1993-05-17 2001-01-29 CHO cell sialidase by recombinant DNA technology

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6258693A 1993-05-17 1993-05-17
US062586 1993-05-17
US18732794A 1994-01-25 1994-01-25
US187327 1994-01-25
AU68349/94A AU6834994A (en) 1993-05-17 1994-05-17 Cho cell sialidase by recombinant dna technology

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU68349/94A Division AU6834994A (en) 1993-05-17 1994-05-17 Cho cell sialidase by recombinant dna technology

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU16688/01A Division AU771747B2 (en) 1993-05-17 2001-01-29 CHO cell sialidase by recombinant DNA technology

Publications (1)

Publication Number Publication Date
AU7841998A true AU7841998A (en) 1998-10-01

Family

ID=26742448

Family Applications (2)

Application Number Title Priority Date Filing Date
AU68349/94A Abandoned AU6834994A (en) 1993-05-17 1994-05-17 Cho cell sialidase by recombinant dna technology
AU78419/98A Abandoned AU7841998A (en) 1993-05-17 1998-07-27 CHO cell sialidase by recombinant DNA technology

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU68349/94A Abandoned AU6834994A (en) 1993-05-17 1994-05-17 Cho cell sialidase by recombinant dna technology

Country Status (13)

Country Link
US (1) US5928915A (en)
EP (2) EP0866130B1 (en)
JP (1) JPH08510133A (en)
AT (2) ATE175239T1 (en)
AU (2) AU6834994A (en)
CA (1) CA2160458A1 (en)
DE (2) DE69415669T2 (en)
DK (2) DK0700443T3 (en)
ES (2) ES2128562T3 (en)
GR (1) GR3029781T3 (en)
NZ (1) NZ266714A (en)
PT (1) PT866130E (en)
WO (1) WO1994026908A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562588B2 (en) * 1993-05-17 2003-05-13 Genentech, Inc. Sialidase and recombinant cell lines
JP3088681B2 (en) * 1997-05-22 2000-09-18 宮城県 Plasma membrane-localized sialidase and DNA encoding the same
US6261805B1 (en) * 1999-07-15 2001-07-17 Boyce Thompson Institute For Plant Research, Inc. Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
KR100604258B1 (en) * 1999-12-30 2006-07-31 씨제이 주식회사 Method for enhancing in vivo activity of glycoproteins
AU2002222436A1 (en) * 2001-12-14 2003-06-30 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A reporter gene
ATE540967T1 (en) * 2004-01-30 2012-01-15 Amgen Inc METHOD FOR PURIFYING PROTEINS
WO2007108464A1 (en) * 2006-03-20 2007-09-27 Kyowa Hakko Kogyo Co., Ltd. Antibody directed against mammal-derived cytoplasmic sialidase
ES2492469T3 (en) * 2007-02-20 2014-09-09 Dsm Ip Assets B.V. New sialidase
EP2141178A4 (en) 2007-04-02 2010-05-19 Kyowa Hakko Kirin Co Ltd Method of producing antithrombin composition
EP2930245B1 (en) * 2007-10-12 2017-11-22 Sigma-Aldrich Co. LLC Cell line and methods for improved glycoprotein sialylation
JP2008263996A (en) * 2008-06-02 2008-11-06 National Institute Of Advanced Industrial & Technology Method for producing and refining light-emitting beetle-derived red luciferase-stabilized form
US11060083B2 (en) 2013-07-19 2021-07-13 Larix Bioscience Llc Methods and compositions for producing double allele knock outs
CN105392885B (en) * 2013-07-19 2020-11-03 赖瑞克斯生物科技公司 Methods and compositions for generating double allele knockouts
ES2915378T3 (en) 2013-09-13 2022-06-22 Hoffmann La Roche Methods for detecting and quantifying a host cell protein in cell lines
NZ756750A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
CN112795583A (en) * 2020-11-16 2021-05-14 上海大学 Preparation method of recombinant sialic acid exonuclease, expression gene, recombinant expression vector and construction method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912040A (en) * 1986-11-14 1990-03-27 Genetics Institute, Inc. Eucaryotic expression system
US5075218A (en) * 1987-12-29 1991-12-24 Biomira, Inc. Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
WO1993010260A1 (en) * 1991-11-21 1993-05-27 The Board Of Trustees Of The Leland Stanford Junior University Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases

Also Published As

Publication number Publication date
EP0700443A1 (en) 1996-03-13
DE69435304D1 (en) 2010-09-02
NZ266714A (en) 1997-12-19
PT866130E (en) 2010-10-26
EP0866130B1 (en) 2010-07-21
CA2160458A1 (en) 1994-11-24
WO1994026908A1 (en) 1994-11-24
GR3029781T3 (en) 1999-06-30
ATE474925T1 (en) 2010-08-15
US5928915A (en) 1999-07-27
AU6834994A (en) 1994-12-12
DK0866130T3 (en) 2010-10-04
DE69415669T2 (en) 1999-07-01
DE69415669D1 (en) 1999-02-11
DK0700443T3 (en) 1999-08-30
ES2346941T3 (en) 2010-10-21
ATE175239T1 (en) 1999-01-15
JPH08510133A (en) 1996-10-29
EP0700443B1 (en) 1998-12-30
ES2128562T3 (en) 1999-05-16
EP0866130A1 (en) 1998-09-23

Similar Documents

Publication Publication Date Title
AU7841998A (en) CHO cell sialidase by recombinant DNA technology
IL87737A (en) Method for culturing polypeptide factor dependent vertebrate recombinant cells
IE870738L (en) Improvements in or to antibiotic
AU4270985A (en) Yeast vector integrates into host chromosome
ATE284954T1 (en) HYALURONAN SYNTHASE GENE AND ITS USE
DK127786D0 (en) METHOD FOR MANUFACTURING TGF-BETA, DNA AND MRNA CODING TGF-BETA, AND REPLICABLE VECTORS INCLUDING THE DNA AND HOST CELL-CONTAINING VECTORS
AU2875492A (en) Recombinant core-streptavidin
BR9802403A (en) Protein having transglutaminase activity, DNA, transforming, and, process to produce a protein having transglutaminase activity.
AU6650486A (en) Production of thrombin inhibitors
KR960010863A (en) Recombinant methacidine and preparation method thereof
FI960663A (en) DNA sequence encoding an A. thaliana protein with delta-5,7-sterol, delta-7 reductase activity, i.e. delta-7-Red protein, process for its preparation, altered yeast strains and applications
WO1993024633A3 (en) METHOD FOR PRODUCTION AND RECOVERY OF POLY-β-HYDROXYBUTYRATE FROM TRANSFORMED $i(ESCHERICHIA COLI)
AU2085195A (en) Gene coding for igg-fc-binding protein
AU7508694A (en) Novel tyrosine kinase
KR850004275A (en) Promoter and its use
EP0336383A3 (en) Novel recombinant human lymphotoxin
ATE129287T1 (en) BACTERIAL COLLAGENASE GENE.
AU4682685A (en) Recombinant saccharomyces
ATE125868T1 (en) NEW TYLOSIN BIOSYNTHESIS GENES.
Barsomian et al. Endo F-free PNGase
Aviv et al. Bacterial expression of porcine growth hormone
WO2003048361A3 (en) P55pik
WO2003054010A3 (en) Early stage redox-related apoptosis modulator-2 (esram-2)

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted